• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Device Problems Patient-Device Incompatibility (2682); Biocompatibility (2886)
Patient Problems Chest Pain (1776); Dyspnea (1816); Fatigue (1849); Headache (1880); Hypersensitivity/Allergic reaction (1907); Rash (2033); Palpitations (2467)
Event Type  Injury  
Manufacturer Narrative
As reported in a research article, asd occluders were explanted due to the patient's nickel allergy.The instructions for use, 600035-021 version 1, warns that an allergic reaction to the device may occur if the patient is allergic to nickel.The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
It was reported through a research article identifying amplatzers that may be related to surgical explants.Specific patient information is documented as unknown.Details are listed in the attached article, titled surgical explant of asd occluder for nickel allergy symptoms, patient reported outcomes.It was reported in a study that 55 atrial septal closure devices were explanted due to nickel allergy.Of the 55 devices, 31 of the devices were amplatzer and 24 of the devices were gore helix.The symptoms that were experienced by most patients include chest pain, headaches/migraines, skin rash, palpitations, breathlessness on exertion, and fatigue.The onset of symptoms were one day to nine months post implant.Four of the 55 patients had complications post implant.Two patients had supraventricular arrhythmias and two patients had refractory serous pericarditis requiring pericardiectomy.Post explant procedure, all patients reported enhanced satisfaction and improvement in symptoms.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
pamela yip
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key9345079
MDR Text Key169321356
Report Number2135147-2019-00391
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 11/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/11/2019
Initial Date FDA Received11/19/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
-
-